Clinical Trials Directory

Trials / Unknown

UnknownNCT04021212

Pituitary Adenoma and Serum Lipid

Effects of Pituitary Adenoma Resection on Serum Lipid Level

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Shandong Provincial Hospital · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Pituitary adenomas are usually benign monoclonal neoplasms caused by a mixture of pituicyte alterations together with a changed endocrine and paracrine regulatory milieu. Thus, it can cause serious health problems such as abnormal target organ function, pain, disability and even death. In clinical practice, we found many patients with pituitary adenomas are usually accompanied by hyperlipidemia, which is the main cause of cardiovascular diseases. However, it has been unclear if there is an association between pituitary adenomas and serum lipid profile. In the present study, we aim to focus on the patients with pituitary adenomas and their lipid profile before and after operation including first occurrence and recurrence.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2019-07-16
Last updated
2022-05-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04021212. Inclusion in this directory is not an endorsement.

Pituitary Adenoma and Serum Lipid (NCT04021212) · Clinical Trials Directory